• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® PROPATEN® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® PROPATEN® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER Back to Search Results
Model Number HT066080A
Device Problem Material Separation (1562)
Patient Problem Unspecified Vascular Problem (4441)
Event Date 01/25/2021
Event Type  Injury  
Manufacturer Narrative
Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium apl, which in covalently bound to the device surface and is essentially|non-eluting.
 
Event Description
The following was reported to gore: on an unknown date (7months ago) a gore® propaten® vascular graft (vg) was placed in the superficial femoral artery for treatment of occlusion.On (b)(6) 2021, a gore® viabahn® endoprosthesis (vsx) was placed in the common iliac for treatment of stenosis.The physician was unable to gain access in the upper arm due to the diseased state of the patient's vessels.So the physician decided to gain access from the vg that was previously implanted (on an unknown date).The physician cut down into the vg and inserted a 7fr introducer sheath.The vsx was successfully deployed in the native vessel above the vg device in the common iliac.The patient did not experience any adverse consequences.On (b)(6) 2021, the patient had low ankle-brachial index (abi) and an ultra sound was performed.It was noticed that the low abi was coming from the vg and what appeared to be a separation of the graft's inner lumen.On (b)(6) 2021, the decision was made to reline the vg with a 6mm x 25cm vsx.The patient did not experience any adverse consequences.
 
Manufacturer Narrative
H6 - investigation findings, code updated to 3221 (no findings available).H6 - investigation conclusions, code updated to 4315 (cause not established).
 
Manufacturer Narrative
Corrected h6 - component code.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® PROPATEN® VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
nick lafave
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key11289408
MDR Text Key230690005
Report Number2017233-2021-01652
Device Sequence Number1
Product Code DSY
UDI-Device Identifier00733132606641
UDI-Public00733132606641
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
K062161
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 04/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/05/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/23/2023
Device Model NumberHT066080A
Device Catalogue NumberHT066080A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/04/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/24/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage A
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Other;
-
-